世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 Hospital Acquired Infection Control Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
The global hospital acquired infection (HAI) control market is undergoing significant transformation due to increased focus on healthcare hygiene and patient safety. According to Fairfield Market R... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe global hospital acquired infection (HAI) control market is undergoing significant transformation due to increased focus on healthcare hygiene and patient safety. According to Fairfield Market Research, the market is projected to grow from USD 7.3 billion in 2025 to USD 9.7 billion by the end of 2032, reflecting a CAGR of 4.14% during the forecast period. Rising infection rates, especially post-COVID-19, and technological advancements in sterilization and disinfection equipment are key drivers shaping this market’s growth trajectory.Market Insights Hospital-acquired infections continue to pose a major risk to patients, with medical facilities focusing more on implementing effective control strategies. The demand for disinfection and sterilization technologies has risen sharply due to increasing awareness about the consequences of HAIs, along with strict government mandates aimed at improving hygiene standards across hospitals and clinics. One of the primary reasons for market growth is the growing number of surgical procedures, which increase the risk of infection. In tandem with this, rising chronic illness prevalence and aging populations are necessitating longer hospital stays, further amplifying the need for robust infection control solutions. Drivers Several factors are propelling the expansion of the hospital acquired infection control market: • Increased Surgical Interventions: A growing volume of surgeries has led to heightened demand for infection prevention protocols and equipment. • Government Initiatives: Public health authorities across the globe have launched campaigns and funding programs to improve hospital hygiene and prevent HAIs. • Awareness & Education: Rising awareness among healthcare professionals and patients about the benefits of proper sterilization and hygiene practices is reinforcing market demand. • Technological Advancements: The introduction of automated and smart disinfection systems, such as UV-based and cloud-connected equipment, is revolutionizing infection control procedures. Business Opportunity The post-pandemic era has significantly amplified awareness and investment in infection control infrastructure. This has created fresh opportunities for manufacturers of sterilization and disinfection devices. Companies introducing portable, quick, and cloud-based sterilization solutions are likely to witness strong adoption across hospital and outpatient settings. Furthermore, the growing preference for outpatient services and minimally invasive procedures supports the expansion of infection control systems in ambulatory surgical centers and clinics. As hygiene standards become more stringent, even small-scale diagnostic laboratories are expected to invest in advanced infection control systems. Region Analysis • United States: With a highly advanced healthcare system and substantial investments in medical infrastructure, the U.S. remains a dominant player, driven by a high incidence of HAIs and strong awareness levels. • China: The country is emerging as a fast-growing market due to increased government spending on healthcare and efforts to reduce HAI rates. Ventilator-associated and hospital-acquired pneumonia remain major concerns. • India: Ongoing healthcare reforms, infrastructure development, and growing public awareness are making India a lucrative destination for infection control equipment providers. • Europe: A mature healthcare sector and well-established hygiene protocols continue to support consistent market performance across major EU countries. Key Players The market Analysis is characterized by intense competition and innovation, with several companies pursuing strategic initiatives to expand their global footprint. Notable developments include: • PURioLABS launched a portable disinfection cabinet designed to rapidly sterilize frequently used instruments. • Unimech Healthcare unveiled the UniClean series with UVGI and cloud connectivity to support scalable disinfection. • STERIS plc acquired Cantel Medical to strengthen its infection control offerings across various medical verticals. • UVision360 Inc. received approval for expanded reprocessing with its LUMINELLE DTx System. Major players include Olympus Corporation, Medivators Inc. (Cantel Medical Corp.), Getinge Group, STERIS Plc., Belimed AG (Metall Zug), Steelco S.P.A, Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co., Advanced Sterilization Products Services Inc. (Johnson & Johnson), Abbott Laboratories, Bayer AG, Alere Inc., The 3M Company, Cepheid Inc., and UVision360 Inc. Segmentation By Product • Heat Sterilization Equipment o Moist Heat Sterilization Equipment o Dry Heat Sterilization Equipment • Low-Temperature Sterilization Equipment • Radiation Sterilization Equipment • Disinfection Equipment o Disinfector § Washer Disinfector § Flusher Disinfector o Endoscopic Reprocessor Systems § Single Basin § Dual Basin o Disinfectants By End User • Hospitals • Ambulatory Surgical Centres • Medical Institutions • Diagnostic Laboratories • Clinics By Region • North America • Latin America • Europe • South Asia • East Asia • Oceania • Middle East & Africa Table of Contents1. Executive Summary1.1. Global Hospital Acquired Infection Control Market Snapshot 1.2. Future Projections 1.3. Key Market Trends 1.4. Regional Snapshot, by Value, 2025 1.5. Analyst Recommendations 2. Market Overview 2.1. Market Definitions and Segmentations 2.2. Market Dynamics 2.2.1. Drivers 2.2.2. Restraints 2.2.3. Market Opportunities 2.3. Value Chain Analysis 2.4. Porter’s Five Forces Analysis 2.5. COVID-19 Impact Analysis 2.5.1. Supply 2.5.2. Demand 2.6. Impact of Ukraine-Russia Conflict 2.7. Economic Overview 2.7.1. World Economic Projections 2.8. PESTLE Analysis 3. Global Hospital Acquired Infection Control Market Outlook, 2019-2032 3.1. Global Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032 3.1.1. Key Highlights 3.1.1.1. Heat Sterilization Equipment 3.1.1.1.1. Moist Heat Sterilization Equipment 3.1.1.1.2. Dry Heat Sterilization Equipment 3.1.1.2. Low-Temperature Sterilization Equipment 3.1.1.3. Radiation Sterilization Equipment 3.1.1.4. Disinfection Equipment 3.1.1.4.1. Disinfector 3.1.1.4.1.1. Disinfector 3.1.1.4.1.1.1. Washer Disinfector 3.1.1.4.1.1.2. Flusher Disinfector 3.1.1.4.2. Flusher Disinfector 3.1.1.5. Endoscopic Reprocessor Systems 3.1.1.5.1. Single Basin Endoscopic Reprocessor Systems 3.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems 3.1.1.6. Disinfectants 3.2. Global Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032 3.2.1. Key Highlights 3.2.1.1. Hospitals 3.2.1.2. Ambulatory Surgical Centres 3.2.1.3. Medical Institutions 3.2.1.4. Diagnostic Laboratories 3.2.1.5. Clinics 3.3. Global Hospital Acquired Infection Control Market Outlook, by Region, Value (US$ Bn) and Volume (Million Units), 2019-2032 3.3.1. Key Highlights 3.3.1.1. North America 3.3.1.2. Europe 3.3.1.3. Asia Pacific 3.3.1.4. Latin America 3.3.1.5. Middle East & Africa 4. North America Hospital Acquired Infection Control Market Outlook, 2019-2032 4.1. North America Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032 4.1.1. Key Highlights 4.1.1.1. Heat Sterilization Equipment 4.1.1.1.1. Moist Heat Sterilization Equipment 4.1.1.1.2. Dry Heat Sterilization Equipment 4.1.1.2. Low-Temperature Sterilization Equipment 4.1.1.3. Radiation Sterilization Equipment 4.1.1.4. Disinfection Equipment 4.1.1.4.1. Disinfector 4.1.1.4.1.1. Disinfector 4.1.1.4.1.1.1. Washer Disinfector 4.1.1.4.1.1.2. Flusher Disinfector 4.1.1.4.2. Flusher Disinfector 4.1.1.5. Endoscopic Reprocessor Systems 4.1.1.5.1. Single Basin Endoscopic Reprocessor Systems 4.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems 4.1.1.6. Disinfectants 4.2. North America Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032 4.2.1. Key Highlights 4.2.1.1. Hospitals 4.2.1.2. Ambulatory Surgical Centres 4.2.1.3. Medical Institutions 4.2.1.4. Diagnostic Laboratories 4.2.1.5. Clinics 4.3. North America Hospital Acquired Infection Control Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032 4.3.1. Key Highlights 4.3.1.1. U.S. Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032 4.3.1.2. U.S. Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032 4.3.1.3. Canada Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032 4.3.1.4. Canada Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032 4.3.2. BPS Analysis/Market Attractiveness Analysis 5. Europe Hospital Acquired Infection Control Market Outlook, 2019-2032 5.1. Europe Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032 5.1.1. Key Highlights 5.1.1.1. Heat Sterilization Equipment 5.1.1.1.1. Moist Heat Sterilization Equipment 5.1.1.1.2. Dry Heat Sterilization Equipment 5.1.1.2. Low-Temperature Sterilization Equipment 5.1.1.3. Radiation Sterilization Equipment 5.1.1.4. Disinfection Equipment 5.1.1.4.1. Disinfector 5.1.1.4.1.1. Disinfector 5.1.1.4.1.1.1. Washer Disinfector 5.1.1.4.1.1.2. Flusher Disinfector 5.1.1.4.2. Flusher Disinfector 5.1.1.5. Endoscopic Reprocessor Systems 5.1.1.5.1. Single Basin Endoscopic Reprocessor Systems 5.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems 5.1.1.6. Disinfectants 5.2. Europe Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032 5.2.1. Key Highlights 5.2.1.1. Hospitals 5.2.1.2. Ambulatory Surgical Centres 5.2.1.3. Medical Institutions 5.2.1.4. Diagnostic Laboratories 5.2.1.5. Clinics 5.3. Europe Hospital Acquired Infection Control Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032 5.3.1. Key Highlights 5.3.1.1. Germany Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032 5.3.1.2. Germany Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032 5.3.1.3. U.K. Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032 5.3.1.4. U.K. Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032 5.3.1.5. France Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032 5.3.1.6. France Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032 5.3.1.7. Italy Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032 5.3.1.8. Italy Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032 5.3.1.9. Turkey Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032 5.3.1.10. Turkey Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032 5.3.1.11. Russia Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032 5.3.1.12. Russia Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032 5.3.1.13. Rest of Europe Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032 5.3.1.14. Rest of Europe Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032 5.3.2. BPS Analysis/Market Attractiveness Analysis 6. Asia Pacific Hospital Acquired Infection Control Market Outlook, 2019-2032 6.1. Asia Pacific Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032 6.1.1. Key Highlights 6.1.1.1. Heat Sterilization Equipment 6.1.1.1.1. Moist Heat Sterilization Equipment 6.1.1.1.2. Dry Heat Sterilization Equipment 6.1.1.2. Low-Temperature Sterilization Equipment 6.1.1.3. Radiation Sterilization Equipment 6.1.1.4. Disinfection Equipment 6.1.1.4.1. Disinfector 6.1.1.4.1.1. Disinfector 6.1.1.4.1.1.1. Washer Disinfector 6.1.1.4.1.1.2. Flusher Disinfector 6.1.1.4.2. Flusher Disinfector 6.1.1.5. Endoscopic Reprocessor Systems 6.1.1.5.1. Single Basin Endoscopic Reprocessor Systems 6.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems 6.1.1.6. Disinfectants 6.2. Asia Pacific Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032 6.2.1. Key Highlights 6.2.1.1. Hospitals 6.2.1.2. Ambulatory Surgical Centres 6.2.1.3. Medical Institutions 6.2.1.4. Diagnostic Laboratories 6.2.1.5. Clinics 6.3. Asia Pacific Hospital Acquired Infection Control Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032 6.3.1. Key Highlights 6.3.1.1. China Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032 6.3.1.2. China Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032 6.3.1.3. Japan Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032 6.3.1.4. Japan Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032 6.3.1.5. South Korea Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032 6.3.1.6. South Korea Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032 6.3.1.7. India Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032 6.3.1.8. India Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032 6.3.1.9. Southeast Asia Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032 6.3.1.10. Southeast Asia Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032 6.3.1.11. Rest of Asia Pacific Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032 6.3.1.12. Rest of Asia Pacific Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032 6.3.2. BPS Analysis/Market Attractiveness Analysis 7. Latin America Hospital Acquired Infection Control Market Outlook, 2019-2032 7.1. Latin America Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032 7.1.1. Key Highlights 7.1.1.1. Heat Sterilization Equipment 7.1.1.1.1. Moist Heat Sterilization Equipment 7.1.1.1.2. Dry Heat Sterilization Equipment 7.1.1.2. Low-Temperature Sterilization Equipment 7.1.1.3. Radiation Sterilization Equipment 7.1.1.4. Disinfection Equipment 7.1.1.4.1. Disinfector 7.1.1.4.1.1. Disinfector 7.1.1.4.1.1.1. Washer Disinfector 7.1.1.4.1.1.2. Flusher Disinfector 7.1.1.4.2. Flusher Disinfector 7.1.1.5. Endoscopic Reprocessor Systems 7.1.1.5.1. Single Basin Endoscopic Reprocessor Systems 7.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems 7.1.1.6. Disinfectants 7.2. Latin America Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032 7.2.1. Key Highlights 7.2.1.1. Hospitals 7.2.1.2. Ambulatory Surgical Centres 7.2.1.3. Medical Institutions 7.2.1.4. Diagnostic Laboratories 7.2.1.5. Clinics 7.3. Latin America Hospital Acquired Infection Control Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032 7.3.1. Key Highlights 7.3.1.1. Brazil Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032 7.3.1.2. Brazil Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032 7.3.1.3. Mexico Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032 7.3.1.4. Mexico Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032 7.3.1.5. Argentina Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032 7.3.1.6. Argentina Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032 7.3.1.7. Rest of Latin America Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032 7.3.1.8. Rest of Latin America Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032 7.3.2. BPS Analysis/Market Attractiveness Analysis 8. Middle East & Africa Hospital Acquired Infection Control Market Outlook, 2019-2032 8.1. Middle East & Africa Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032 8.1.1. Key Highlights 8.1.1.1. Heat Sterilization Equipment 8.1.1.1.1. Moist Heat Sterilization Equipment 8.1.1.1.2. Dry Heat Sterilization Equipment 8.1.1.2. Low-Temperature Sterilization Equipment 8.1.1.3. Radiation Sterilization Equipment 8.1.1.4. Disinfection Equipment 8.1.1.4.1. Disinfector 8.1.1.4.1.1. Disinfector 8.1.1.4.1.1.1. Washer Disinfector 8.1.1.4.1.1.2. Flusher Disinfector 8.1.1.4.2. Flusher Disinfector 8.1.1.5. Endoscopic Reprocessor Systems 8.1.1.5.1. Single Basin Endoscopic Reprocessor Systems 8.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems 8.1.1.6. Disinfectants 8.2. Middle East & Africa Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032 8.2.1. Key Highlights 8.2.1.1. Hospitals 8.2.1.2. Ambulatory Surgical Centres 8.2.1.3. Medical Institutions 8.2.1.4. Diagnostic Laboratories 8.2.1.5. Clinics 8.3. Middle East & Africa Hospital Acquired Infection Control Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032 8.3.1. Key Highlights 8.3.1.1. GCC Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032 8.3.1.2. GCC Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032 8.3.1.3. South Africa Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032 8.3.1.4. South Africa Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032 8.3.1.5. Egypt Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032 8.3.1.6. Egypt Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032 8.3.1.7. Nigeria Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032 8.3.1.8. Nigeria Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032 8.3.1.9. Rest of Middle East & Africa Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032 8.3.1.10. Rest of Middle East & Africa Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032 8.3.2. BPS Analysis/Market Attractiveness Analysis 9. Competitive Landscape 9.1. Product vs End User Heatmap 9.2. Manufacturer vs End User Heatmap 9.3. Company Market Share Analysis, 2025 9.4. Competitive Dashboard 9.5. Company Profiles 9.5.1. Olympus Corporation 9.5.1.1. Company Overview 9.5.1.2. Product Portfolio 9.5.1.3. Financial Overview 9.5.1.4. Business Strategies and Development 9.5.2. Medivators Inc. (Cantel Medical Corp.) 9.5.2.1. Company Overview 9.5.2.2. Product Portfolio 9.5.2.3. Financial Overview 9.5.2.4. Business Strategies and Development 9.5.3. Getinge Group 9.5.3.1. Company Overview 9.5.3.2. Product Portfolio 9.5.3.3. Financial Overview 9.5.3.4. Business Strategies and Development 9.5.4. STERIS Plc. 9.5.4.1. Company Overview 9.5.4.2. Product Portfolio 9.5.4.3. Financial Overview 9.5.4.4. Business Strategies and Development 9.5.5. Belimed AG (Metall Zug) 9.5.5.1. Company Overview 9.5.5.2. Product Portfolio 9.5.5.3. Financial Overview 9.5.5.4. Business Strategies and Development 9.5.6. Steelco S.P.A. 9.5.6.1. Company Overview 9.5.6.2. Product Portfolio 9.5.6.3. Financial Overview 9.5.6.4. Business Strategies and Development 9.5.7. Pfizer Inc., 9.5.7.1. Company Overview 9.5.7.2. Product Portfolio 9.5.7.3. Financial Overview 9.5.7.4. Business Strategies and Development 9.5.8. F. Hoffmann-La Roche Ltd, 9.5.8.1. Company Overview 9.5.8.2. Product Portfolio 9.5.8.3. Financial Overview 9.5.8.4. Business Strategies and Development 9.5.9. Merck & Co., 9.5.9.1. Company Overview 9.5.9.2. Product Portfolio 9.5.9.3. Financial Overview 9.5.9.4. Business Strategies and Development 9.5.10. Advanced Sterilization Products Services Inc. (Johnson & Johnson), 9.5.10.1. Company Overview 9.5.10.2. Product Portfolio 9.5.10.3. Financial Overview 9.5.10.4. Business Strategies and Development 9.5.11. Abbott Laboratories 9.5.11.1. Company Overview 9.5.11.2. Product Portfolio 9.5.11.3. Financial Overview 9.5.11.4. Business Strategies and Development 9.5.12. Bayer AG 9.5.12.1. Company Overview 9.5.12.2. Product Portfolio 9.5.12.3. Financial Overview 9.5.12.4. Business Strategies and Development 9.5.13. The 3M Company 9.5.13.1. Company Overview 9.5.13.2. Product Portfolio 9.5.13.3. Financial Overview 9.5.13.4. Business Strategies and Development 9.5.14. Cepheid Inc. 9.5.14.1. Company Overview 9.5.14.2. Product Portfolio 9.5.14.3. Financial Overview 9.5.14.4. Business Strategies and Development 9.5.15. UVision360 Inc. 9.5.15.1. Company Overview 9.5.15.2. Product Portfolio 9.5.15.3. Financial Overview 9.5.15.4. Business Strategies and Development 10. Appendix 10.1. Research Methodology 10.2. Report Assumptions 10.3. Acronyms and Abbreviations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療機器）の最新刊レポート
Fairfield Market Research社の 医療機器分野 での最新刊レポート
本レポートと同じKEY WORD（hospital）の最新刊レポート
よくあるご質問Fairfield Market Research社はどのような調査会社ですか?Fairfield Market Researchでは、最新かつ最も関連性の高い市場データと洞察に満ちた詳細なレポートを発行しています。広範囲にわたり、業界動向や市場ベースのデータを含んでおり、顧客が... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
